These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 1627637

  • 1. Tissue lipid accumulation by L-aminocarnitine, an inhibitor of carnitine-palmitoyltransferase-2. Studies in intact rats and isolated mitochondria.
    Chiodi P, Maccari F, Ramacci MT.
    Biochim Biophys Acta; 1992 Jul 09; 1127(1):81-6. PubMed ID: 1627637
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase.
    Brady PS, Brady LJ.
    Biochem J; 1986 Sep 15; 238(3):801-9. PubMed ID: 3800962
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aminocarnitine and related compounds as inhibitors of carnitine transferases: physiologic implications.
    Nutr Rev; 1990 Jun 15; 48(6):258-60. PubMed ID: 1365754
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Liver mitochondria, confirmed as intact by complete suppression of succinate uptake and oxidation, possess a carnitine palmitoyltransferase I that is totally inhibited by malonyl CoA.
    Abo-Hashema KA, Cake MH, Potter IC.
    Biochem Biophys Res Commun; 1999 May 19; 258(3):778-83. PubMed ID: 10329463
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane.
    Murthy MS, Pande SV.
    Proc Natl Acad Sci U S A; 1987 Jan 19; 84(2):378-82. PubMed ID: 3540964
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carbonyl-Co-A on mitochondrial oxidations.
    Turnbull DM, Bartlett K, Younan SI, Sherratt HS.
    Biochem Pharmacol; 1984 Feb 01; 33(3):475-81. PubMed ID: 6704164
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DL-aminocarnitine and acetyl-DL-aminocarnitine. Potent inhibitors of carnitine acyltransferases and hepatic triglyceride catabolism.
    Jenkins DL, Griffith OW.
    J Biol Chem; 1985 Nov 25; 260(27):14748-55. PubMed ID: 3840486
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation.
    Chegary M, Te Brinke H, Doolaard M, Ijlst L, Wijburg FA, Wanders RJ, Houten SM.
    Mol Genet Metab; 2008 Apr 25; 93(4):403-10. PubMed ID: 18077198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.